The psychedelic revolution isn’t coming – it’s here. Ketamine is a legal medicine, and MDMA and psilocybin are on the fast track to becoming FDA-approved. However, the majority of healthcare providers on the front lines of patient care are unaware of the burgeoning field of psychedelic-based therapeutics.
What good is revolutionary psychedelic medicine if physicians aren’t comfortable talking about them let alone recommending, or even prescribing them?
The Psychedelic Medicine Association (PMA) is a public benefit corporation of healthcare providers aimed at bridging the gap between the advances taking place in the psychedelic research world and medical practitioners.
Join Our Community of Over 1200 Healthcare Professionals
Our community of healthcare professionals is dedicated to advancing the field of healthcare through education, networking, and collaboration. As a member of our association, you will have access to a wealth of resources designed to help you stay up-to-date on the latest industry trends and best practices.
Monthly newsletters with the latest findings from the world of psychedelic research.
Monthly Members-only webinars featuring panels of experts members can interact with directly.
Multiple forums where members can ask questions, exchange ideas, and discuss best practices.
Members-only journal club led by experts. Go above and beyond to understand the science.
Exclusive members-only discounts on our CME/CE accredited conferences and courses.
Sign up to recieve our FREE introductory guide to psychedelic medicine.